Showing 301-310 of 985 results for "".
Psoriasis Treatment in 2025: More Options, Better Outcomes
https://practicaldermatology.com/issues/august-2025/psoriasis-treatment-in-2025-more-options-better-outcomes/36706/We have better drugs to treat psoriasis than almost any other dermatologic disease state. For patients, it is an excellent time to have psoriasis.Clinical Insights and Emerging Therapeutic Options for Chronic Hand Eczema
https://practicaldermatology.com/issues/october-2025/clinical-insights-and-emerging-therapeutic-options-for-chronic-hand-eczema/39763/Chronic hand eczema (CHE) represents a significant clinical challenge in dermatology practice, affecting approximately 5% of the population—a prevalence approximately twice that of psoriasis.Physician Spotlight: Shawn Kwatra, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-shawn-kwatra-md/23997/The Clinical Significance of Gene Expression Profile Testing for Melanoma
https://practicaldermatology.com/topics/practice-management/the-clinical-significance-of-gene-expression-profile-testing-for-melanoma/20647/Accumulated evidence on GEP Classification suggests that it provides clinically relevant information that can influence patient management for the better.The Hedgehog Pathway: Updates in Safety and Efficacy in Basal Cell Carcinoma Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-hedgehog-pathway-updates-in-safety-and-efficacy-in-basal-cell-carcinoma-treatment/21418/Recent findings may improve how physicians understand BCCs and, more specifically, how hedgehog inhibitors can be harnessed to treat them.In-Review: Two New Melanoma Agents Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/in-review-two-new-melanoma-agents-approved/21534/Utilizing genetic abnormalities, new therapies are carving out new possibilities for melanoma treatment.The Benefits of Private Practice: A Q&A with Joel Schlessinger, MD, FAAD
https://practicaldermatology.com/issues/september-2025/the-benefits-of-private-practice-a-qa-with-joel-schlessinger-md-faad/37630/While selling to and working for private equity–backed platforms may have its perks, many long-time private practitioners warn that the advantages of private practice are often not fully appreciated until it is too late. Practical Dermatology Chief Cosmetic Surgery Editor Emeritus Joel Schlessinger,Medical Education and Technology: Intertwined like the Rod of Asclepius
https://practicaldermatology.com/columns/clinical-focus-1/medical-education-and-technology-intertwined-like-the-rod-of-asclepius/23453/EGFR Inhibitor-induced Acneiform Rash: A Review of Current Management Strategies
https://practicaldermatology.com/topics/general-topics/egfr-inhibitor-induced-acneiform-rash-a-review-of-current-management-strategies/21517/What Is Really Going On In Psoriatic Skin?
https://practicaldermatology.com/topics/psoriasis/what-is-really-going-on-in-psoriatic-skin/20648/Take a walk through the pathogenesis of psoriasis to understand how new and emerging therapies may offer benefit.